Businesswire News Releases

Businesswire News Releases

May 10, 2024 21:24 ET
Altimmune, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Altimmune, Inc. (ALT) Class Action
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Altimmune, Inc. (NASDAQ: ALT) securities between December 1, 2023 and April 26, 2024. Altimmune is a clinical stage biopharmaceutical company that focuses on developing treatments for obesity and l...
May 10, 2024 18:55 ET
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759 restricted stock units (RSUs) of the company’s common stock to 14 newly hired non-executive em...
May 10, 2024 18:52 ET
KBRA Assigns Ratings to SILAC Insurance Company and Sterling Investors Life Insurance Company
KBRA assigns BBB insurance financial strength ratings to SILAC Insurance Company ("SILAC") and Sterling Investors Life Insurance Company ("SILIC"). The Outlook for both ratings is Stable....
May 10, 2024 18:34 ET
ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of ARCA biopharma, Inc. (the “Company”) (NasdaqCM: ABIO) and Oruka Therapeutics. Upon closing of the proposed transaction, ARCA shareholders are expected to own approximately 2.38% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, and whether the merger is fair to ARCA shareholders....
May 10, 2024 18:07 ET
Terran Orbital Schedules Conference Call to Discuss First Quarter 2024 Financial Results
Terran Orbital Corporation (NYSE: LLAP) (“Terran Orbital” or the “Company”), a global leader in satellite-based solutions primarily serving the aerospace and defense industries, today announced it will host the Company’s first quarter 2024 earnings conference call at 11:00 a.m. E.T. on May 14, 2024....
May 10, 2024 18:06 ET
Best’s Commentary: Low Agribusiness Exposure to Help Brazil’s Reinsurers Weather Floods
Due to reduced exposures in volatile lines of business such as agribusiness, (re)insurance companies in Brazil should be able to weather any impacts from the recent widespread flooding in Rio Grande do Sul, according to an AM Best commentary....
May 10, 2024 17:30 ET
Vroom Announces First Quarter 2024 Results
Vroom, Inc. (Nasdaq:VRM) today announced financial results for the first quarter ended March 31, 2024....
May 10, 2024 17:01 ET
Sky Harbour to Report 2024 Q1 Results and Host Webcast Investor Call Tuesday, May 14, 2024
Sky Harbour Group Corporation (NYSE American: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation infrastructure company building the first nationwide network of Home-Basing campuses for business aircraft, today announced that it will release its First Quarter 2024 financial results after market close on Tuesday, May 14, 2024, and to host an investor webcast at 5:00 pm ET the same day. On the call, Sky Harbour will review quarterly financial results and provide a general business update. A question-and-answer session with Sky Harbour leadership will follow. Both the call and webcast are open ...
May 10, 2024 16:31 ET
HCA Healthcare, Inc. to Present at June Healthcare Conference
HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conference:...
May 10, 2024 16:30 ET
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s Board...
May 10, 2024 16:30 ET
Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) announced that the stockholders at a Special Meeting held today overwhelmingly approved adopting a Plan of Dissolution. Following that announcement, the Board of Directors declared a liquidating cash dividend in the amount of $15.10 per share. The dividend is expected to be paid on or about May 17, 2024. Merrimack’s Common Stock will trade on NASDAQ through May 17, 2024 and will delist from NASDAQ on May 20, 2024....
May 10, 2024 16:15 ET
GE Vernova Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
GE Vernova Inc. (NYSE: GEV) today announced that it received notice of an unsolicited “mini-tender” offer by TRC Capital Investment Corporation (TRC Capital) to purchase up to 1,000,000 shares of GE Vernova common stock, which represents approximately 0.4% of the shares outstanding, at a price of $155.00 per share in cash. TRC Capital’s offer price is 7.39% less than the $167.36 closing price per share of GE Vernova’s common stock on May 7, 2024, the last trading day before the mini-tender offer appears to have commenced....
May 10, 2024 16:05 ET
RLI Names Deb Millum as Vice President, Claim
RLI Corp. (NYSE: RLI) -- RLI Corp. announced today the promotion of Deb Millum to Vice President, Claim. In her new role, Millum will assume executive leadership and oversight responsibility for RLI’s Transportation, Non-Transportation Auto and Personal Umbrella product claims....
May 10, 2024 16:00 ET
HEI Reports First Quarter 2024 Results
“We continue to work in earnest with key stakeholders to help our community recover from the devastating impacts of the Maui wildfires. The State’s One ‘Ohana fund has seen steady uptake and the Governor recently extended the registration deadline, and mediation discussions are underway with those impacted by the fires. Hawaii’s legislative session recently concluded, and although we are disappointed that we ran out of time to pass legislation this session, our governor and legislature are highly engaged in determining how to design legislation that best makes sense for Hawaii, our customers a...
May 10, 2024 15:39 ET
Crawford & Company Board Declares Dividends
Crawford & Company® (NYSE: CRD-A and CRD-B) is pleased to announce that on May 10, 2024, at its regular quarterly meeting, the Board of Directors declared a quarterly dividend of $0.07 per share on the Class A Common Stock and $0.07 per share on the Class B Common Stock, payable on June 7, 2024, to shareholders of record as of the close of business on May 24, 2024....
May 10, 2024 15:18 ET
Morgan Group Holding Co. Reports First Quarter Results
Morgan Group Holding Co. (“MGHL” or the “Company”; OTC Pink®: MGHL) reports preliminary unaudited financial results for the quarter ended March 31, 2024....
May 10, 2024 14:32 ET
Ossium Health Launches HOPE Program to Give All Patients Hope for a Cure
Ossium Health, an innovative bioengineering company that established a first-of-its-kind bone marrow bank, announced today the launch of a new program that further expands patient access to Ossium’s bone marrow. Through the HOPE (HPC Offered for PRESERVE Expansion) Program, patients that need an allogeneic bone marrow transplant but are ineligible to participate in Ossium’s active clinical study (PRESERVE I) have a new opportunity to receive bone marrow from Ossium’s bank....
May 10, 2024 14:01 ET
Hyatt Doubles Down on Latin America Growth with 30+ Planned Openings Through 2027
Hyatt Hotels Corporation (NYSE: H) highlighted today Hyatt’s expected growth trajectory, from the sought-after beach town of Miches, Dominican Republic to the lush island of St. Lucia, World of Hyatt guests and members will soon have more than 30 new hotels to consider in Latin America & the Caribbean. Through 2027,
May 10, 2024 13:25 ET
The Baldwin Group Announces Upsize and Pricing of $600 Million Offering of Senior Secured Notes due 2031
The Baldwin Group, the go-to-market brand name for The Baldwin Insurance Group, Inc. (formerly BRP Group, Inc.) (“Baldwin”) (NASDAQ: BRP), announced today the pricing of the previously announced offering by its direct subsidiary The Baldwin Insurance Group Holdings, LLC (“Baldwin Holdings”) and a wholly-owned corporate subsidiary of Baldwin Holdings of $600 million (representing an upsize from the previously announced $500 million) aggregate principal amount of senior secured notes due 2031 (the “notes”)....
May 10, 2024 13:23 ET
Bayer to Present Investigational Data from Comprehensive KERENDIA® (finerenone) Clinical Trial Program at Heart Failure 2024 Congress
Bayer will present Kerendia® (finerenone) data from its comprehensive clinical trial program in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in addition to data from FINEARTS-HF, the ongoing randomized, double-blind, placebo-controlled, multicenter, event-driven Phase III study is investigating the efficacy (including CV death and total HF events) and safety of finerenone compared to placebo in patients suffering from symptomatic HF with an ejection fraction of ≥40% (HFmrEF/HFpEF), at Heart Failure 2024, a scientific congress of the European Society of...


Top